Depression in Parkinson's disease: the effectiveness and risk of pharmacotherapy. Clinical review.

Parkinson's disease (PD) is a neurological disease with a heterogeneous pattern of neurological symptoms and concomitant psychiatric syndromes. These syndromes are triggered by alterations to neurotransmission that are likely common for both neurological and psychiatric symptoms. Syndromes such as depression, anxiety, or cognitive impairment can precede motor symptoms of PD and delay its diagnosis.

Bupropion in the treatment of depression in Parkinson's disease.

A 78-year-old female with a nine-year history of depression was hospitalized due to worsening depression and symptoms associated with Parkinson's disease (PD). Her motor abilities improved on levodopa and the depression improved after a trial of bupropion, following unsuccessful treatment with other antidepressants. We found four reports on successful treatment of depression in PD with bupropion.

[Stigma and related factors basing on mental illness stigma].

Stigmatization is a common problem to overcome for people suffering from chronic diseases. It usually follows infectious diseases, disabilities and mental disorders. In our study we explained basic concepts concerning stigma, particularly health-related one, and then we presented the most important socio-demographic factors influencing attitudes towards mentally ill people exemplifying them by scientific literature on mental illness stigma.

[Corneal endothelial density in glaucoma patients].

Purpose: To asses mean endothelial cell density in glaucoma patients.

Material And Methods: Examinations were conducted and registered using the Noncon Robo (Konan) non-contact specular microscope between years 2000 and 2004, in Tadeusz Krwawicz Chair of Ophthalmology and 1st Eye Hospital, Medical University of Lublin. The results of 159 patients (233 eyes) with glaucoma and 37 patients (44 eyes) with pseudoexfoliation syndrome were analyzed.